NCT03678558已完成不适用
Cytochalasin B for Oocyte Vitrification
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 612
- 试验地点
- 1
- 主要终点
- survival after thawing
研究概览
简要总结
Using the cytoskeleton Stabilizer the Cytochalasin B would improve the outcome of oocyte vitrification.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- Triple (Participant, Care Provider, Investigator)
入排标准
- 年龄范围
- 18 Years 至 42 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •indication for oocyte vitrification
排除标准
- 未提供
研究组 & 干预措施
Cytochalasin B supplemented vitrification medium
Experimental
干预措施: Cytochalasin B supplemented vitrification medium (Other)
Vitrification medium with no supplementation
No Intervention
结局指标
主要结局
survival after thawing
时间窗: 6 days of culture
次要结局
- ongoing pregnancy rate(12 months)
- fertilization rate(6 days of culture)
- clinical pregnancy rate(three months)
- Rates of blastocyst formation and quality(6 days of culture)
- embryo utilisation rate(6 days of culture)
研究者
Muhammad Fawzy
IVF Lab Director
Ibn Sina Hospital
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Oocyte Vitrification Aided With Latrunculin AInfertilityNCT03678571Ibn Sina Hospital400
已完成
不适用
Oocyte Vitrification for In Vitro Fertilization (IVF) Patients and Women With Fertility Threatening ConditionsFertility PreservationNCT01448460University of Louisville8
招募中
不适用
Vitrification of Oocytes Matured by CAPA-IVMFertility PreservationNCT06157619Centro de Fertilidad y Reproducción Asistida, Peru20
已完成
Unknown
Investigation of methods to prevent oocyte degeneration in minimally invasive ICSIoneJPRN-UMIN000050410Kusuhara Women's Clinic170
已完成
早期 1 期
Effect of Oocyte Vitrification on Fertilization Rate, Embryo Quality and DevelopmentFertilityNCT01422395Main Line Fertility Center40